Interestingly, there is strong evidence that decreased ACE2 and Ang(1–7) levels are associated with poor prognosis in patients with respiratory dysfunction, including ALI and ARDS, similar to COVID-19 [3,8,41]. This evidence concerns the gene ACE2 and COVID-19.